Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
SER150TBS phase II trial in type 2 diabetes with diabetic nephropathy and albuminuria
2014-003985-25Phase 2Completed
- Sponsor
- Serodus
- Start
- Feb 2015
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of EV-077 in diabetic glomerulosclerosis, albuminuria and type 2 diabetes mellitus (T2DM) (4 arms), sponsored by Serodus. Primary endpoint: Safety endpoint. Started Feb 2015; status: completed.
02
Drugs
EV-077
03
Conditions
diabetic glomerulosclerosisalbuminuriatype 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on 2014-003985-25.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2014-003985-25.